It Tech Packaging, Inc 8-K, filed Aug 11, 2021
It Tech Packaging, Inc. (ITP)
About this 8-K
It Tech Packaging, Inc filed this 8-K on August 11, 2021, reporting on events of August 10, 2021.
Items reported
- Item 2.02: Financial results
- Item 9.01: Financial statements and exhibits
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, DC 20549
FORM
CURRENT REPORT
Pursuant to Section 13 or 15(d) of the
Securities Exchange Act of 1934
Date of report (Date of earliest event reported):
(Exact name of registrant as specified in its charter)
(State or other jurisdiction of incorporation)
| (Commission File Number) | (IRS Employer Identification No.) |
|
|
||
| (Address of principal executive offices) | (Zip Code) |
(Registrant’s telephone number, including area code)
(Former name or former address, if changed since last report)
Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (see General Instruction A.2. below):
| Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425) |
| Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12) |
| Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b)) |
| Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c)) |
Securities registered pursuant to Section 12(b) of the Act:
| Title of each class | Trading symbol(s) | Name of each exchange on which registered | ||
Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (17 CFR §230.405) or Rule 12b-2 of the Securities Exchange Act of 1934 (17 CFR §240.12b-2).
Emerging growth company
If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐
| Item 2.02 | Results of Operations and Financial Condition. |
On August 10, 2021, IT Tech Packaging, Inc. (the “Company”) issued a press release announcing its unaudited financial results for the quarter ended June 30, 2021. A copy of the press release making the announcement is attached as Exhibit 99.1 to this Current Report on Form 8-K and is incorporated herein by reference.
The information furnished pursuant to this Item 2.02, including Exhibit 99.1, shall not be deemed as “filed” for purposes of Section 18 of the Securities Exchange Act of 1934, as amended (the “Exchange Act”), or otherwise subject to the liabilities of that section, and shall not be incorporated by reference into any registration statement or other document filed under the Securities Act of 1933, as amended (the “Securities Act”), or the Exchange Act, except as shall be expressly set forth by specific reference in such filing.
| Item 9.01 | Financial Statements and Exhibits. |
(d) Exhibits.
The following exhibits are filed herewith:
| Exhibit Number | Description | |
| 99.1 | Press Release dated August 10, 2021, announcing unaudited financial results of the Company for the quarter ended June 30, 2021. | |
| 104 | Cover Page Interactive Data File (embedded within the Inline XBRL document) |
1
SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.
| IT TECH PACKAGING, INC. | |||
| Date: August 11, 2021 | By: | /s/ Zhenyong Liu | |
| Name: | Zhenyong Liu | ||
| Title: | Chief Executive Officer | ||
2
Exhibit 99.1
IT Tech Packaging, Inc. Announces Second Quarter 2021 Unaudited Financial Results
Company to Host Earnings Conference Call on Wednesday, August 11, 2021, at 8:00 am ET
BAODING, China, August 10, 2021 /PRNewswire/ -- IT Tech Packaging, Inc. (NYSE American: ITP) (“IT Tech Packaging” or the “Company”), a leading manufacturer and distributor of diversified paper products in North China, announced today its unaudited financial results for the second quarter ended June 30, 2021.
Second Quarter 2021 Unaudited Financial Results
| For the Three Months Ended June 30, | ||||||||||||
| ($ millions) | 2021 | 2020 | % Change | |||||||||
| Revenues | 46.53 | 26.36 | 76.5 | % | ||||||||
| Regular Corrugating Medium Paper (“CMP”)* | 30.25 | 17.37 | 74.1 | % | ||||||||
| Light-Weight CMP** | 6.56 | 4.50 | 45.7 | % | ||||||||
| Offset Printing Paper | 7.18 | 1.26 | 469.2 | % | ||||||||
| Tissue Paper Products | 2.43 | 2.38 | 2.0 | % | ||||||||
| Face Masks | 0.11 | 0.85 | -87.1 | % | ||||||||
| Gross profit | 3.03 | 2.56 | 18.4 | % | ||||||||
| Gross profit (loss) margin | 6.5 | % | 9.7 | % | -3.2 | pp**** | ||||||
| Regular Corrugating Medium Paper (“CMP”)* | 5.1 | % | 9.0 | % | -3.9 | pp**** | ||||||
| Light-Weight CMP** | 6.7 | % | 12.5 | % | -5.8 | pp**** | ||||||
| Offset Printing Paper | 17.8 | % | 23.7 | % | -5.9 | pp**** | ||||||
| Tissue Paper Products*** | -9.6 | % | -15.7 | % | 6.1 | pp**** | ||||||
| Face Masks | 10.0 | % | 59.5 | % | -49.5 | pp**** | ||||||
| Operating income (loss) | 0.43 | -0.80 | 154.0 | % | ||||||||
| Net loss | -0.45 | -0.98 | -53.8 | % | ||||||||
| EBITDA | 9.03 | 2.90 | 210.9 | % | ||||||||
| Basic and Diluted earnings (loss) per share | -0.01 | -0.04 | 75.8 | % | ||||||||
* Products from PM6
** Products from PM1
*** Products from PM8 and PM9
**** pp represents percentage points
| ● | Revenue increased by 76.5% to $46.53 million, primarily attributable to the increase in sales volume of CMP and offset printing paper, as well as the increase in Average Selling Prices (“ASPs”) of CMP and tissue paper products. |
| ● | Gross profit was $3.03 million, compared to $2.56 million for the same period of last year. Gross margin was 6.5%, compared to 9.7% for the same period of last year. |
| ● | Income from operations was $0.43 million, compared to the loss from operations of $0.80 million for the same period of last year. Operating income margin was 0.9% for the second quarter of 2021. |
| ● | Net loss was $0.45 million, or loss per share of $0.01, compared to net loss of $0.98 million, or loss per share of $0.04, for the same period of last year. |
| ● | Earnings before interest, taxes, depreciation and amortization (“EBITDA”) was $9.03 million, compared to $2.90 million for the same period of last year. |
Mr. Zhenyong Liu, Chairman and Chief Executive Officer of the Company, commented, “We continued to making improvements in the sales volume of CMP and offset printing paper products for this quarter. Our total revenue increased by 76.5% to $46.5 million, resulting from a 33.9% growth of overall sales volume and a 36.0% increase in average selling prices over all categories of products. We recorded a 18.4% increase of gross profit and an operating income of $0.43 million.
Amid robust domestic market demand for tissue paper products and improved production efficiency, we continue to expand our capacity by launching a new tissue paper production line(“PM10”)that will greatly boost our overall performance. The Company has obtained approval for surgical mask products from local Food and Drug Administration and has completed all preparation and testing works at the mask production line with an annual estimated production capacity of 45 million pieces of masks, potentially creating promising financial returns. The Company obtained the first batch of new utility patents to keep its great work on technology innovation in the future. In addition, we are also expanding the business to high and new technology business such as combined heat and power generation project utilizing bio mass technology project (“Biomass CHP Project”) and expect to diversify our sources of revenue and ensure our stable modes of profit-making.”
Revenue
For the second quarter of 2021, total revenue increased by $20.17 million, or 76.5%, to $46.53 million from $26.36 million for the same period of last year. The increase in total revenue was mainly due to the increase in sales volume of CMP and offset printing paper and average selling prices of CMP and tissue paper products. The following table summarizes revenue, volume and ASPs by products for the second quarter of 2021 and 2020, respectively:
| For the Three Months Ended June 30, | ||||||||||||||||||||||||
| 2021 | 2020 | |||||||||||||||||||||||
| Revenue ($’000) | Volume (tonne) | ASP ($/tonne) | Revenue ($’000) | Volume (tonne) | ASP ($/tonne) | |||||||||||||||||||
| Regular CMP | 30,252 | 60,507 | 500 | 17,372 | 46,980 | 370 | ||||||||||||||||||
| Light-Weight CMP | 6,561 | 13,491 | 486 | 4,503 | 12,611 | 357 | ||||||||||||||||||
| Offset Printing Paper | 7,184 | 10,415 | 690 | 1,262 | 2,183 | 578 | ||||||||||||||||||
| Tissue Paper Products | 2,428 | 2,196 | 1,106 | 2,380 | 2,884 | 825 | ||||||||||||||||||
| Total | 46,426 | 86,609 | 536 | 25,517 | 64,658 | 395 | ||||||||||||||||||
| Revenue ($’000) | Volume (thousand pieces) | ASP ($/thousand pieces) | Revenue ($’000) | Volume ($/thousand pieces) | ASP ($/thousand pieces) | |||||||||||||||||||
| Face Masks | 109 | 2,635 | 41 | 846 | 6,280 | 135 | ||||||||||||||||||
2
Revenue from CMP, including both regular CMP and Light-Weight CMP, increased by $14.94 million, or 68.3%, to $36.81 million and accounted for 79.1% of total revenue for the second quarter of 2021, compared to $21.87 million, or 83.0% of total revenue, for the same period of last year. The Company sold 73,998 tonnes of CMP at an ASP of $497/tonne in the second quarter of 2021, compared to 59,591 tonnes at an ASP of $367/tonne in the same period of last year.
Of the total CMP sales, revenue from regular CMP increased by $12.88 million, or 74.1%, to $30.25 million, resulting from sales of 60,507 tonnes at an ASP of $500/tonne, during the second quarter of 2021, compared to revenue of $17.37 million, resulting from sales of 46,980 tonnes at an ASP of $370/tonne, for the same period of last year. Revenue from light-weight CMP increased by $2.06 million, or 45.7%, to $6.56 million, resulting from sales of 13,491 tonnes at an ASP of $486/tonne for the second quarter of 2021, compared to revenue of $4.50 million, resulting from sales of 12,611 tonnes at an ASP of $357/tonne for the same period of last year.
Revenue from offset printing paper increased by $5.92 million, or 469.2%, to $7.18 million for the second quarter of 2021, from $1.26 million for the same period of last year. The Company sold 10,415 tonnes of offset printing paper at an ASP of $690/tonne in the second quarter of 2021, compared to sales volume of 2,183 tonnes of offset printing paper at an ASP of $578/tonne for the same period of last year.
Revenue from tissue paper products increased by $0.05 million, or 2.0%, to $2.43 million, resulting from sales of 2,196 tonnes at an ASP of $1,106/tonne, for the second quarter of 2021, compared to revenue of $2.38 million, resulting from sales of 2,884 tonnes at an ASP of $825/tonne for the same period of last year.
Revenue generated from selling face masks was $0.11 million for the second quarter of 2021. The Company sold 2,635 thousand pieces of face masks in the second quarter of 2021.
Gross Profit (Loss) and Gross Profit (Loss) Margin
Total cost of sales increased by $19.70 million, or 82.8%, to $43.51 million for the second quarter of 2021, from $23.80 million for the same period of last year. The increase in total cost of sales was mainly due to the increase in sales volume of CMP and offset printing paper products, as well as increase in material costs. Costs of sales per tonne for regular CMP, light-weight CMP, offset printing paper and tissue paper products were $475, $454, $567 and $1,211, respectively, for the second quarter of 2021, compared to $336, $312, $441 and $955 per tonne, respectively, for the same period of last year.
Total gross profit was $3.03 million for the second quarter of 2021, compare to the gross loss of $2.56 million for the same period of last year as a result of factors described above. Overall gross profit margin was 6.5% for the second quarter of 2021, compared to the gross loss margin of 9.7% for the same period of last year. Gross profit (loss) margins for regular CMP, light-weight CMP, offset printing paper, tissue paper and face mask products were 5.1%, 6.7%, 17.8%, -9.6% and 10.0%, respectively, for the second quarter of 2021, compared to 9.0%, 12.5%, 23.7%, -15.7% and 59.5%, respectively, for the same period of last year.
3
Selling, General and Administrative Expenses
Selling, general and administrative expenses (“SG&A”) decreased by $0.76 million, or 22.6%, to $2.60 million for the second quarter of 2021 from $3.36 million for the same period of last year. As a percentage of total revenue, SG&A was 5.6% for the second quarter of 2021, compared to 12.7% for the same period of last year.
Loss from Operations
Income from operations was $0.43 million for the second quarter of 2021, compared to the loss from operations of $0.80 million for the same period of last year. The increase in income from operations was primarily due to the increase in gross profit and decrease in selling, general and administrative expenses. Operating income margin was 0.9% for the second quarter of 2021, compared to operating loss margin of 3.0% for the same period of last year.
Net Loss and Net Loss per Share
Net loss was $0.45 million, or $0.01 loss per basic and diluted share, for the second quarter of 2021, compare to the net loss of $0.98 million, or $0.04 per basic and diluted share, for the same period of last year.
EBITDA
EBITDA was $9.03 million for the second quarter of 2021, compared to $2.90 million for the same period of the prior year.
Note 1: Non-GAAP Financial Measures
In addition to our U.S. GAAP results, this press release includes a discussion of EBITDA, a non-GAAP financial measure as defined by the Securities and Exchange Commission (“SEC”). The Company defines EBITDA as net income before interest, income taxes, depreciation and amortization. EBITDA is a key measure used by management to evaluate our results and make strategic decisions. Management believes this measure is useful to investors because it is an indicator of operational performance. Because not all companies use identical calculations, the Company’s presentation of EBITDA may not be comparable to similarly titled measures of other companies, and should not be viewed as an alternative to measures of financial performance or changes in cash flows calculated in accordance with the U.S. GAAP.
| For the Three Months Ended June 30, | ||||||||
| ($ millions) | 2021 | 2020 | ||||||
| Net income (loss) | -0.45 | -0.98 | ||||||
| Add: Income tax | 5.12 | -0.08 | ||||||
| Net interest expense | 0.28 | 0.24 | ||||||
| Depreciation and amortization | 4.07 | 3.72 | ||||||
| EBITDA | 9.03 | 2.90 | ||||||
4
First Half of 2021 Unaudited Financial Results
| For the Six Months Ended June 30, | ||||||||||||
| ($ millions) | 2021 | 2020 | % Change | |||||||||
| Revenues | 70.74 | 35.11 | 101.5 | % | ||||||||
| Regular Corrugating Medium Paper (“CMP”)* | 47.22 | 23.09 | 104.5 | % | ||||||||
| Light-Weight CMP** | 10.31 | 6.52 | 58.2 | % | ||||||||
| Offset Printing Paper | 9.30 | 1.26 | 636.8 | % | ||||||||
| Tissue Paper Products | 3.68 | 3.39 | 8.7 | % | ||||||||
| Face Masks | 0.24 | 0.85 | -71.7 | % | ||||||||
| Gross profit | 4.86 | 2.39 | 103.4 | % | ||||||||
| Gross profit (loss) margin | 6.9 | % | 6.8 | % | 0.1 | pp**** | ||||||
| Regular Corrugating Medium Paper (“CMP”)* | 6.3 | % | 8.0 | % | -1.7 | pp**** | ||||||
| Light-Weight CMP** | 8.3 | % | 12.6 | % | -4.3 | pp**** | ||||||
| Offset Printing Paper | 18.1 | % | 23.7 | % | -5.6 | pp**** | ||||||
| Tissue Paper Products*** | -18.7 | % | -32.1 | % | 13.4 | pp**** | ||||||
| Face Masks | 14.8 | % | 59.5 | % | -44.7 | pp**** | ||||||
| Operating income (loss) | -0.29 | -3.67 | 92.0 | % | ||||||||
| Net loss | -4.79 | -3.42 | -40.3 | % | ||||||||
| EBITDA | 8.96 | 3.96 | 126.2 | % | ||||||||
| Basic and Diluted earnings (loss) per share | -0.10 | -0.14 | 26.5 | % | ||||||||
* Products from PM6
** Products from PM1
*** Products from PM8 and PM9
**** pp represents percentage points
Revenue
For the first half of 2021, total revenue increased by $35.64 million, or 101.5%, to $70.74 million from $35.11 million for the same period of last year. The increase in total revenue was mainly due to the increase in sales volume of CMP and offset printing paper and average selling prices of CMP and tissue paper products. The following table summarizes revenue, volume and ASPs by products for the first half of 2021 and 2020, respectively:
| For the Six Months Ended June 30, | ||||||||||||||||||||||||
| 2021 | 2020 | |||||||||||||||||||||||
| Revenue ($’000) | Volume (tonne) | ASP ($/tonne) | Revenue ($’000) | Volume (tonne) | ASP ($/tonne) | |||||||||||||||||||
| Regular CMP | 47,216 | 94,133 | 502 | 23,094 | 60,767 | 380 | ||||||||||||||||||
| Light-Weight CMP | 10,309 | 21,161 | 487 | 6,518 | 17,500 | 372 | ||||||||||||||||||
| Offset Printing Paper | 9,300 | 13,557 | 686 | 1,262 | 2,183 | 578 | ||||||||||||||||||
| Tissue Paper Products | 3,680 | 3,317 | 1,109 | 3,386 | 4,069 | 832 | ||||||||||||||||||
| Total | 70,505 | 132,168 | 533 | 34,261 | 84,519 | 405 | ||||||||||||||||||
| Revenue ($’000) | Volume (thousand pieces) | ASP ($/thousand pieces) | Revenue ($’000) | Volume ($/thousand pieces) | ASP ($/thousand pieces) | |||||||||||||||||||
| Face Masks | 239 | 6,470 | 37 | 846 | 6,280 | 135 | ||||||||||||||||||
5
Revenue from CMP, including both regular CMP and Light-Weight CMP, increased by $27.91 million, or 94.3%, to $57.53 million and accounted for 81.3% of total revenue for the first half of 2021, compared to $29.61 million, or 84.4% of total revenue, for the same period of last year. The Company sold 115,294 tonnes of CMP at an ASP of $499/tonne in the first half of 2021, compared to 78,267 tonnes at an ASP of $378/tonne in the same period of last year.
Of the total CMP sales, revenue from regular CMP increased by $24.12 million, or 104.5%, to $47.22 million, resulting from sales of 94,133 tonnes at an ASP of $502/tonne, during the first half of 2021, compared to revenue of $23.09 million, resulting from sales of 60,767 tonnes at an ASP of $380/tonne, for the same period of last year. Revenue from light-weight CMP increased by $3.79 million, or 58.2%, to $10.31 million, resulting from sales of 21,161 tonnes at an ASP of $487/tonne for the first half of 2021, compared to revenue of $6.52 million, resulting from sales of 17,500 tonnes at an ASP of $372/tonne for the same period of last year.
Revenue from offset printing paper increased by $8.04 million, or 636.8%, to $9.30 million for the first half of 2021, from $1.26 million for the same period of last year. The Company sold 13,557 tonnes of offset printing paper at an ASP of $686/tonne in the first half of 2021, compared to sales volume of 2,183 tonnes of offset printing paper at an ASP of $578/tonne for the same period of last year.
Revenue from tissue paper products increased by $0.29 million, or 8.7%, to $3.68 million, resulting from sales of 3,317 tonnes at an ASP of $1,109/tonne, for the first half of 2021, compared to revenue of $3.39 million, resulting from sales of 4,069 tonnes at an ASP of $832/tonne for the same period of last year.
Revenue generated from selling face masks was $0.24 million for the first half of 2021. The Company sold 6,470 thousand pieces of face masks in the first half of 2021.
Gross Profit (Loss) and Gross Profit (Loss) Margin
Total cost of sales increased by $33.17 million, or 101.4%, to $65.88 million for the first half of 2021, from $32.72 million for the same period of last year. The increase in total cost of sales was mainly due to the increase in sales volume of CMP and offset printing paper products, as well as increase in material costs. Costs of sales per tonne for regular CMP, light-weight CMP, offset printing paper and tissue paper products were $470, $447, $562 and $1,317, respectively, for the first half of 2021, compared to $350, $325, $441 and $1,099, respectively, for the same period of last year.
Total gross profit was $4.86 million for the first half of 2021, compare to $2.39 million for the same period of last year as a result of factors described above. Overall gross profit margin was 6.9% for the first half of 2021, compared to 6.8% for the same period of last year. Gross profit (loss) margins for regular CMP, light-weight CMP, offset printing paper, tissue paper and face mask products were 6.3%, 8.3%, 18.1%, -18.7% and 14.8%, respectively, for the first half of 2021, compared to 8.0%, 12.6%, 23.7%, -32.1% and 59.5%, respectively, for the same period of last year.
6
Selling, General and Administrative Expenses
Selling, general and administrative expenses (“SG&A”) decreased by $0.90 million, or 14.9%, to $5.15 million for the first half of 2021 from $6.05 million for the same period of last year.
Loss from Operations
Loss from operations was $0.29 million for the first half of 2021, compared to the loss from operations of $3.67 million for the same period of last year. The decrease in loss from operations was primarily due to the increase in gross profit and decrease in selling, general and administrative expenses. Operating loss margin was 0.4% for the first half of 2021, compared to operating loss margin of 10.4% for the same period of last year.
Net Loss and Net Loss per Share
Net loss was $4.79 million, or $0.10 loss per basic and diluted share, for the first half of 2021, compare to the net loss of $3.42 million, or $0.14 per basic and diluted share, for the same period of last year.
EBITDA
EBITDA was $8.96 million for the first half of 2021, compared to $3.96 million for the same period of the prior year.
Note 1: Non-GAAP Financial Measures
In addition to our U.S. GAAP results, this press release includes a discussion of EBITDA, a non-GAAP financial measure as defined by the Securities and Exchange Commission (“SEC”). The Company defines EBITDA as net income before interest, income taxes, depreciation and amortization. EBITDA is a key measure used by management to evaluate our results and make strategic decisions. Management believes this measure is useful to investors because it is an indicator of operational performance. Because not all companies use identical calculations, the Company’s presentation of EBITDA may not be comparable to similarly titled measures of other companies, and should not be viewed as an alternative to measures of financial performance or changes in cash flows calculated in accordance with the U.S. GAAP.
| For the Six Months Ended June 30, | ||||||||
| ($ millions) | 2021 | 2020 | ||||||
| Net income (loss) | -4.79 | -3.42 | ||||||
| Add: Income tax | 5.02 | -0.61 | ||||||
| Net interest expense | 0.56 | 0.49 | ||||||
| Depreciation and amortization | 8.17 | 7.50 | ||||||
| EBITDA | 8.96 | 3.96 | ||||||
7
Cash, Liquidity and Financial Position
As of June 30, 2021, the Company had cash and bank balances, short-term debt (including bank loans, current portion of long-term loans from credit union and related party loans), and long-term debt (including related party loans) of $30.27 million, $10.29 million and $6.55 million, respectively, compared to $4.14 million, $12.16 million and $4.60 million, respectively, at the end of 2020.
Net accounts receivable was $5.59 million as of June 30, 2021, compared to $2.39 million as of December 31, 2020. Net inventory was $11.67 million as of June 30, 2021, compared to $1.23 million at the end of 2020. As of June 30, 2021, the Company had current assets of $63.74 million and current liabilities of $17.19 million, resulting in a working capital of $46.55 million. This was compared to current assets of $14.91 million and current liabilities of $18.34 million, resulting in a working capital deficit of $3.43 million at the end of 2020.
Net cash used in operating activities was $15.57 million for the first half of 2021, compared to net cash provided by operating activities of $5.86 million for the same period of last year. Net cash used in investing activities was $0.17 million for the first half of 2021, compared to $0.98 million for the same period of last year. Net cash provided by financing activities was $41.67 million for the first half of 2021, compared to net cash from financing activities of $2.27 for the same period of last year.
Recent development
On May 26, 2021, the Company announced it has officially obtained approval for surgical mask products from local Food and Drug Administration (FDA) in China Hebei province. IT Tech Packaging has also shown the result in public for the required period of time and is now eligible to produce (aseptic) single-use surgical and surgical masks.
On July 6, 2021, the Company announced that the Company’s tissue paper research and development center has received a Level B scale-above Certification as an industrial R&D enterprise institution in Hebei province after on-site inspection by regulators. ITP has also been granted six new utility patent certificates on paper manufacturing related equipment by the State Intellectual Property Office.
Earnings Conference Call
The Company’s management will host a conference call to discuss its second quarter 2021 financial results at 8:00 am US Eastern Time on Wednesday, August 11, 2021. To attend the conference call, please use the information below.
Date/Time: 8:00 am US Eastern Time (8:00 PM Beijing/Hong Kong Time) on Wednesday, August 11, 2021
Conference Title: IT Tech Packaging, Inc. Second Quarter 2021 Earnings Conference Call
Conference ID: 2582868
8
To attend the conference call, please register in advance of the conference using the link: http://apac.directeventreg.com/registration/event/2582868 to complete the online registration at least 15 minutes prior to the start of the call. Upon registering, the conference access information including participant dial-in numbers, a Direct Event passcode and a registrant ID will be provided to you via an email.
This conference call will be broadcast live on the Internet and can be accessed by all interested parties at https://edge.media-server.com/mmc/p/ye5haonx. Please access the link at least 15 minutes prior to the start of the call to register, download, and install any necessary audio software.
A playback will be available through 11:00 am ET on August 11, 2021 to 9:59 am ET on August 19, 2021. To listen, please dial+1-855-452-5696 if calling from the United States, or +61-281-990-299 if calling internationally. Use the conference ID 2582868 to access the replay.
About IT Tech Packaging, Inc.
Founded in 1996, IT Tech Packaging, Inc. is a leading manufacturer and distributor of diversified paper products in North China. Using recycled paper as its primary raw material (with the exception of its tissue paper products), ITP produces and distributes three categories of paper products: corrugating medium paper, offset printing paper and tissue paper products. With production based in Baoding and Xingtai in North China’s Hebei Province, ITP is located strategically close to the Beijing and Tianjin region, home to a growing base of industrial and manufacturing activities and one of the largest markets for paper products consumption in the country. ITP has been listed on the NYSE American since December 2009. For more information, please visit: http://www.itpackaging.cn/ .
Safe Harbor Statements
This press release may contain forward-looking statements. These forward-looking statements involve inherent risks and uncertainties that could cause actual results to differ materially from those projected or anticipated, including risks outlined in the Company’s public filings with the Securities and Exchange Commission, including the Company’s latest annual report on Form 10-K. All information provided in this press release speaks as of the date hereof. Except as otherwise required by law, the Company undertakes no obligation to update or revise its forward-looking statements.
For more information, please contact:
At the Company Email:
ir@itpackaging.cn
Tel: +86 0312 8698215
Investor Relations:
Janice Wang
EverGreen Consulting Inc.
Email: ir@changqingconsulting.com
9
IT TECH PACKAGING, INC.
CONDENSED CONSOLIDATED BALANCE SHEETS
AS OF JUNE 30, 2021 AND DECEMBER 31, 2020
(unaudited)
| June 30, | December 31, | |||||||
| 2021 | 2020 | |||||||
| ASSETS | ||||||||
| Current Assets | ||||||||
| Cash and bank balances | $ | 30,273,543 | $ | 4,142,437 | ||||
| Restricted cash | - | - | ||||||
| Accounts receivable (net of allowance for doubtful accounts of $87,876 and $34,391 as of June 30, 2021 and December 31, 2020, respectively) | 5,593,270 | 2,389,057 | ||||||
| Inventories | 11,671,350 | 1,233,801 | ||||||
| Prepayments and other current assets | 15,247,108 | 7,051,515 | ||||||
| Due from related parties | 955,526 | 92,795 | ||||||
| Total current assets | 63,740,797 | 14,909,605 | ||||||
| Prepayment on property, plant and equipment | 21,361,898 | 21,149,749 | ||||||
| Finance lease right-of-use assets, net | 2,339,145 | 2,397,653 | ||||||
| Property, plant, and equipment, net | 138,564,893 | 145,142,642 | ||||||
| Value-added tax recoverable | 2,537,704 | 2,566,195 | ||||||
| Deferred tax asset non-current | 10,076,731 | 13,708,630 | ||||||
| Total Assets | $ | 238,621,168 | $ | 199,874,474 | ||||
| LIABILITIES AND STOCKHOLDERS’ EQUITY | ||||||||
| Current Liabilities | ||||||||
| Short-term bank loans | $ | 6,422,501 | $ | 6,435,348 | ||||
| Current portion of long-term loans from credit union | 3,142,366 | 4,996,245 | ||||||
| Lease liability | 199,544 | 182,852 | ||||||
| Accounts payable | 742,720 | 592,391 | ||||||
| Advance from customers | 83,454 | 82,625 | ||||||
| Due to related parties | 727,433 | 727,433 | ||||||
| Accrued payroll and employee benefits | 314,223 | 224,930 | ||||||
| Other payables and accrued liabilities | 4,867,038 | 4,838,601 | ||||||
| Income taxes payable | 688,441 | 259,649 | ||||||
| Total current liabilities | 17,187,720 | 18,340,074 | ||||||
| Loans from credit union | 6,547,886 | 4,597,772 | ||||||
| Deferred gain on sale-leaseback | 315,298 | 387,087 | ||||||
| Lease liability - non-current | 254,029 | 354,107 | ||||||
| Derivative liability | 7,072,020 | 1,115,260 | ||||||
| Total liabilities (including amounts of the consolidated VIE without recourse to the Company of $18,427,033 and $17,950,224 as of June 30, 2021 and December 31, 2020, respectively) | 31,376,953 | 24,794,300 | ||||||
| Commitments and Contingencies | ||||||||
| Stockholders’ Equity | ||||||||
| Common stock, 500,000,000 shares authorized, $0.001 par value per share, 99,049,900 and 28,535,816 shares issued and outstanding as of June 30, 2021 and December, 31,2020, respectively | 99,050 | 28,536 | ||||||
| Additional paid-in capital | 88,927,787 | 53,989,548 | ||||||
| Statutory earnings reserve | 6,080,574 | 6,080,574 | ||||||
| Accumulated other comprehensive income | 7,688,114 | 5,740,722 | ||||||
| Retained earnings | 104,448,690 | 109,240,794 | ||||||
| Total stockholders’ equity | 207,244,215 | 175,080,174 | ||||||
| Total Liabilities and Stockholders’ Equity | $ | 238,621,168 | $ | 199,874,474 | ||||
10
IT TECH PACKAGING, INC.
CONDENSED CONSOLIDATED STATEMENTS OF INCOME AND COMPREHENSIVE INCOME
FOR THE THREE AND SIX MONTHS ENDED JUNE 30, 2021 AND 2020
(Unaudited)
| Three Months Ended | Six Months Ended | |||||||||||||||
| June 30, | June 30, | |||||||||||||||
| 2021 | 2020 | 2021 | 2020 | |||||||||||||
| Revenues | $ | 46,534,915 | $ | 26,362,273 | $ | 70,744,342 | $ | 35,106,124 | ||||||||
| Cost of sales | (43,505,895 | ) | (23,803,444 | ) | (65,884,317 | ) | (32,717,014 | ) | ||||||||
| Gross Profit | 3,029,019 | 2,558,829 | 4,860,024 | 2,389,110 | ||||||||||||
| Selling, general and administrative expenses | (2,597,611 | ) | (3,357,472 | ) | (5,152,929 | ) | (6,054,435 | ) | ||||||||
| Income (Loss) from Operations | 431,408 | (798,643 | ) | (292,905 | ) | (3,665,325 | ) | |||||||||
| Other Income (Expense): | ||||||||||||||||
| Interest income | 11,719 | 9,451 | 16,052 | 15,241 | ||||||||||||
| Subsidy income | 1,104 | (979 | ) | 197,891 | 142,019 | |||||||||||
| Interest expense | (283,899 | ) | (241,436 | ) | (562,800 | ) | (486,154 | ) | ||||||||
| Gain (loss) on derivative liability | 4,509,007 | (27,865 | ) | 872,040 | (27,865 | ) | ||||||||||
| Income (Loss) before Income Taxes | 4,669,339 | (1,059,472 | ) | 230,278 | (4,022,084 | ) | ||||||||||
| Provision for Income Taxes | (5,122,587 | ) | 79,441 | (5,022,382 | ) | 605,766 | ||||||||||
| Net Loss | (453,248 | ) | (980,031 | ) | (4,792,104 | ) | (3,416,318 | ) | ||||||||
| Other Comprehensive Income (Loss) | ||||||||||||||||
| Foreign currency translation adjustment | 3,416,162 | 124,179 | 1,947,392 | (2,465,575 | ) | |||||||||||
| Total Comprehensive Income (Loss) | $ | 2,962,914 | $ | (855,852 | ) | $ | (2,844,712 | ) | $ | (5,881,893 | ) | |||||
| Losses Per Share: | ||||||||||||||||
| Basic and Diluted Losses per Share | $ | (0.01 | ) | $ | (0.04 | ) | $ | (0.10 | ) | $ | (0.14 | ) | ||||
| Outstanding – Basic and Diluted | 46,638,550 | 24,444,761 | 46,638,550 | 24,444,761 | ||||||||||||
11
IT TECH PACKAGING, INC.
CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS
FOR THE SIX MONTHS ENDED JUNE 30, 2021 AND 2020
(Unaudited)
| Six Months Ended | ||||||||
| June 30, | ||||||||
| 2021 | 2020 | |||||||
| Cash Flows from Operating Activities: | ||||||||
| Net loss | $ | (4,792,104 | ) | $ | (3,416,318 | ) | ||
| Adjustments to reconcile net income to net cash provided by operating activities: | ||||||||
| Depreciation and amortization | 8,166,403 | 7,496,314 | ||||||
| (Gain) Loss on derivative liability | (872,040 | ) | 27,865 | |||||
| (Recovery from) Allowance for bad debts | 53,074 | (1,525 | ) | |||||
| Share-based compensation and expenses | - | 1,242,000 | ||||||
| Deferred tax | 3,764,689 | (1,021,699 | ) | |||||
| Changes in operating assets and liabilities: | ||||||||
| Accounts receivable | (3,229,340 | ) | (89,311 | ) | ||||
| Prepayments and other current assets | (8,060,524 | ) | 5,739,395 | |||||
| Inventories | (10,412,117 | ) | (4,291,622 | ) | ||||
| Accounts payable | 144,206 | 604,823 | ||||||
| Advance from customers | - | 87,729 | ||||||
| Related parties | (860,721 | ) | 1,878,231 | |||||
| Accrued payroll and employee benefits | 86,928 | (35,990 | ) | |||||
| Other payables and accrued liabilities | 15,529 | (1,394,793 | ) | |||||
| Income taxes payable | 425,654 | (968,474 | ) | |||||
| Net Cash (Used in) Provided by Operating Activities | (15,570,363 | ) | 5,856,625 | |||||
| Cash Flows from Investing Activities: | ||||||||
| Purchases of property, plant and equipment | (171,541 | ) | (981,150 | ) | ||||
| Net Cash Used in Investing Activities | (171,541 | ) | (981,150 | ) | ||||
| Cash Flows from Financing Activities: | ||||||||
| Proceeds from issuance of shares and warrants, net | 41,837,553 | 2,273,360 | ||||||
| Repayment of bank loans | (77,301 | ) | - | |||||
| Payment of capital lease obligation | (88,661 | ) | - | |||||
| Net Cash Provided by Financing Activities | 41,671,591 | 2,273,360 | ||||||
| Effect of Exchange Rate Changes on Cash and Cash Equivalents | 201,419 | (158,550 | ) | |||||
| Net Increase in Cash and Cash Equivalents | 26,131,106 | 6,990,285 | ||||||
| Cash, Cash Equivalents and Restricted Cash - Beginning of Period | 4,142,437 | 5,837,745 | ||||||
| Cash, Cash Equivalents and Restricted Cash - End of Period | $ | 30,273,543 | $ | 12,828,030 | ||||
| Supplemental Disclosure of Cash Flow Information: | ||||||||
| Cash paid for interest, net of capitalized interest cost | $ | 312,344 | $ | 288,463 | ||||
| Cash paid for income taxes | $ | 265,450 | $ | 1,369,690 | ||||
| Cash and bank balances | 30,273,543 | 12,828,030 | ||||||
| Restricted cash | - | - | ||||||
| Total cash, cash equivalents and restricted cash shown in the statement of cash flows | 30,273,543 | 12,828,030 | ||||||
12